ANKRD2
Ankyrin repeat domain-containing protein 2
Also known as: ANKR2_HUMAN, ARPP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9GZV1
- Gene
- ANKRD2
- Ensembl
- ENSG00000165887
- Chromosome
- 10
- Canonical length
- 360 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene encodes a protein that belongs to the muscle ankyrin repeat protein (MARP) family. A similar gene in rodents is a component of a muscle stress response pathway and plays a role in the stretch-response associated with slow muscle function. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
Canonical amino-acid sequenceUniProt
360 residues, UniProt reviewed canonical sequence.
>Q9GZV1|ANKRD2
1 MAKAPSWAGV GALAYKAPEA LWPAEAVMDG TMEDSEAVQR ATALIEQRLA QEEENEKLRG
61 DARQKLPMDL LVLEDEKHHG AQSAALQKVK GQERVRKTSL DLRREIIDVG GIQNLIELRK
121 KRKQKKRDAL AASHEPPPEP EEITGPVDEE TFLKAAVEGK MKVIEKFLAD GGSADTCDQF
181 RRTALHRASL EGHMEILEKL LDNGATVDFQ DRLDCTAMHW ACRGGHLEVV KLLQSHGADT
241 NVRDKLLSTP LHVAVRTGQV EIVEHFLSLG LEINARDREG DTALHDAVRL NRYKIIKLLL
301 LHGADMMTKN LAGKTPTDLV QLWQADTRHA LEHPEPGAEH NGLEGPNDSG RETPQPVPAQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANKRD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 1,142 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 1,142 nTPM
- tongue: 769 nTPM
- heart muscle: 496 nTPM
- kidney: 18 nTPM
- salivary gland: 4.1 nTPM
- cerebral cortex: 3.6 nTPM
Single-cell type
- myonuclei: 248 nCPM
- thymic myoid cells: 143 nCPM
- cardiomyocytes: 62 nCPM
- alveolar cells type 1: 15 nCPM
- epicardial cells: 11 nCPM
- loop of henle epithelial cells: 8.2 nCPM
Immune cell
- neutrophil: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 5.7 nTPM
- hypothalamus: 3.6 nTPM
- thalamus: 3.5 nTPM
- amygdala: 3.1 nTPM
- cerebellum: 3.1 nTPM
- medulla oblongata: 3.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.15
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- muscle contraction
- muscle organ development
- negative regulation of myoblast differentiation
- negative regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
- protein kinase B binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- structural constituent of muscle
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ANKRD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANKRD2 as an antibody target. Whether an autoantibody or antibody against ANKRD2 could matter depends on whether native ANKRD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANKRD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ANKRD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...